Bio Impact Capital LLC Werewolf Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $611 Million
- Q1 2024
A detailed history of Bio Impact Capital LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 2,388,011 shares of HOWL stock, worth $5.11 Million. This represents 2.53% of its overall portfolio holdings.
Number of Shares
2,388,011
Previous 2,388,011
-0.0%
Holding current value
$5.11 Million
Previous $9.22 Million
67.89%
% of portfolio
2.53%
Previous 2.24%
Shares
1 transactions
Others Institutions Holding HOWL
# of Institutions
65Shares Held
26.1MCall Options Held
2.4KPut Options Held
35K-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.17 Million11.32% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.01MShares$6.43 Million0.96% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$6.42 Million0.04% of portfolio
-
Bank Of America Corp Charlotte, NC1.88MShares$4.03 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.69MShares$3.61 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $63.2M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...